What Researchers Did
Researchers conducted a double-blinded study in healthy volunteers to assess if regional sympathectomy, compared to placebo, could enhance transcutaneous oxygen delivery during hyperbaric oxygen exposure.
What They Found
Sympathectomy significantly increased skin temperature by 2.5% and upper limb blood flow by 23% (P < 0.05%) compared to placebo. During hyperbaric oxygen exposure, transcutaneous oxygen (tcPO2) was substantially higher after sympathectomy (409.8+/-98.8 mm Hg) than after placebo (171.3 mm Hg).
What This Means for Canadian Patients
For patients undergoing hyperbaric oxygen therapy, combining it with regional sympathectomy could potentially improve oxygen delivery to tissues. This approach might be considered to enhance the therapeutic benefits of HBO2 in certain clinical scenarios.
Canadian Relevance
This study was not conducted in Canada and does not have a direct Canadian connection.
Study Limitations
A limitation of this study is that it was conducted in healthy volunteers, which may limit the generalizability of the findings to patient populations with underlying conditions.